SEC Company Response from Grant Life Sciences, Inc. (CIK 0001210336) — Jul 15, 2005
Grant Life Sciences, Inc. (CIK 0001210336)
Date: July 15, 2005 · CIK: 0001210336 · Accession: 0001144204-05-021722
AI Filing Summary & Sentiment
File numbers found in text: 333-119425
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
GRANT LIFE SCIENCES, INC.
64 East Winchester, Suite 205
Murray, Utah 84107
July 15, 2005
VIA FACSIMILE AND EDGAR
United States Securities
and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Mary K. Fraser
Re: Grant Life Sciences, Inc.
Registration Statement on Form SB-2
File No. 333-119425
Ladies and Gentlemen:
Grant Life Sciences, Inc. respectfully withdraws its request that the
effective date of the registration statement referred to above be accelerated so
that it will become effective at 4:30 p.m., Eastern Time, on Friday July 15,
2005.
GRANT LIFE SCIENCES, INC.
By: /s/ Stan Yakatan
------------------------------
Name: Stan Yakatan
Title: President and Chief Executive Officer
</TEXT>
</DOCUMENT>